mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.1 |